ClinicalTrials.Veeva

Menu

Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP)

Withings logo

Withings

Status

Enrolling

Conditions

Hypertension

Treatments

Device: Blood pressure measurement

Study type

Interventional

Funder types

Industry

Identifiers

NCT06957847
2025-A00050-49

Details and patient eligibility

About

The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in the general population

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patient older than 18 years;
  • Patient who signed the informed consent form;
  • Patient followed-up at site (in-patient or out-patient);
  • Patient with arm circumference between 22 cm and 42 cm.

Exclusion criteria

  • Patient unable to give a consent or understand properly protocol information;
  • Patient suffering from arrhythmia;
  • Patient with poor quality of Korotkov sounds;
  • Patient for whom K5 sounds are absent;
  • Patient wearing an implantable electric medical device (pacemaker,...);
  • Patient with both upper arms suffering from open wound and/or damaged skin.

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

All patients
Experimental group
Description:
Patients consenting to participate to the study and compliant to the inclusion criteria
Treatment:
Device: Blood pressure measurement

Trial contacts and locations

1

Loading...

Central trial contact

Ruiyi Yang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems